Kwang-Soo Kim

8PUBLICATIONS
59CO-AUTHORS
NanomedicineMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 11, 2025
Pharmacokinetic Analysis of Carboplatin and Fluorescein Brain Retention following Ultrasound-Based Blood-Brain Barrier Opening.

Karl J Habashy, Timothy W Synold, Ye Feng

|Mar 31, 2025
Targeting CHEK2-YBX1&YBX3 regulatory hub to potentiate immune checkpoint blockade response in gliomas.

Heba Ali, Ningjia Zhou, Li Chen

|Feb 20, 2025
Pharmacokinetic analysis of carboplatin and fluorescein brain permanence following ultrasound-based blood-brain barrier opening.

Karl J Habashy, Timothy W Synold, Ye Feng

|Sep 30, 2024
MAPK/ERK signaling in gliomas modulates interferon responses, T cell recruitment, microglia phenotype, and immune checkpoint blockade efficacy.

Kwang-Soo Kim, Junyi Zhang, Víctor A Arrieta

|Jan 31, 2024
Paclitaxel and Carboplatin in Combination with Low-intensity Pulsed Ultrasound for Glioblastoma.

Karl J Habashy, Crismita Dmello, Li Chen

|Nov 08, 2023
ERK1/2 Phosphorylation Predicts Survival in Recurrent Glioblastoma Following Intracerebral and Adjuvant PD-1/CTLA-4 Immunotherapy: A REMARK-guided Analysis.

Víctor A Arrieta, Johnny Duerinck, Kirsten B Burdett

Pageof 2